• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Refractec sees record growth with CK sytem

Article

Irvine, CA-Refractec Inc. is reporting record sales and procedures performed with its ViewPoint CK System, which performs conductive keratoplasty (CK) to treat presbyopia.

Irvine, CA-Refractec Inc. is reporting record sales and procedures performed with its ViewPoint CK System, which performs conductive keratoplasty (CK) to treat presbyopia.

The company said gross revenue soared more than 64% to $7.9 million in the first half of 2004, compared with $4.8 million for the same period last year.

The increase is attributed to a 131% increase in its NearVision CK procedures to 12,778 during the first half of the year, which led to a 175% increase in annuity gross revenue.

Related Videos
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.